US Post-Market Surveillance Study of the Surfacer System

Conditions

• Venous Disease

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Central Venous Access — DEVICE
  The Surfacer® Inside-Out® Access Catheter System is intended to obtain central venous access to facilitate catheter insertion into the central venous system for patients with upper body venous occlusions or other conditions that preclude central venous access by conventional methods.

Study Details

Single arm, observational, multi-center, consecutively enrolling, post-market surveillance study. Treating patients in need of central venous access who have upper body venous occlusions or other conditions that preclude central venous access by conventional methods, and who meet the requirements described in the device labeling.

Key Dates

Start date

Feb 8, 2022

Status verified

May 2026

Primary completion

Dec 15, 2026

Completion

Dec 15, 2026

Study Design

Enrollment

30 participants (estimated)

Primary Outcome Measure

Central Venous Access operational [ Time Frame: 24 hours ]

Central Contacts

• Hannah Susmeyer
  978-758-6166
  [email protected]
• Vicky Brunk, RN
  717-873-3309
  [email protected]

Locations (9)

Find similar trials in Tucson, AZ

Related Studies

• The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
  Recruiting · W.L.Gore & Associates · Stanford, California
• Vascular Lab Resource (VLR) Biorepository
  Recruiting · The Cleveland Clinic · Cleveland, Ohio